Literature DB >> 8937708

Nociceptin induced inhibition of K+ evoked glutamate release from rat cerebrocortical slices.

B Nicol1, D G Lambert, D J Rowbotham, D Smart, A T McKnight.   

Abstract

Nociceptin, an endogenous ligand for the orphan receptor ORL1, has recently been described. In this study we have shown that nociception inhibits 46 mM K(+)-stimulated glutamate release from rat perfused cerebrocortical slices with an IC50 of 51 nM. At 100 nM the inhibition amounted to 68 +/- 14% and was naloxone (10 microM)-insensitive excluding an activation of mu, delta and kappa opioid receptors. These data demonstrate the functional coupling of ORL1 in glutamatergic neurones and implicates a role for nociceptin in glutamatergic neurotransmission.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8937708      PMCID: PMC1915895          DOI: 10.1111/j.1476-5381.1996.tb16007.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  Inhibition of tachykinin release from peripheral endings of sensory nerves by nociceptin, a novel opioid peptide.

Authors:  S Giuliani; C A Maggi
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

2.  The effect of nociceptin on Ca2+ channel current and intracellular Ca2+ in the SH-SY5Y human neuroblastoma cell line.

Authors:  M Connor; A Yeo; G Henderson
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

Review 3.  Opiate receptors.

Authors:  T Reisine
Journal:  Neuropharmacology       Date:  1995-05       Impact factor: 5.250

4.  Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type.

Authors:  J R Bunzow; C Saez; M Mortrud; C Bouvier; J T Williams; M Low; D K Grandy
Journal:  FEBS Lett       Date:  1994-06-27       Impact factor: 4.124

5.  ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization.

Authors:  C Mollereau; M Parmentier; P Mailleux; J L Butour; C Moisand; P Chalon; D Caput; G Vassart; J C Meunier
Journal:  FEBS Lett       Date:  1994-03-14       Impact factor: 4.124

6.  Increase by the ORL1 receptor (opioid receptor-like1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones.

Authors:  C W Vaughan; M J Christie
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

7.  Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor.

Authors:  J C Meunier; C Mollereau; L Toll; C Suaudeau; C Moisand; P Alvinerie; J L Butour; J C Guillemot; P Ferrara; B Monsarrat
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

8.  Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor.

Authors:  R K Reinscheid; H P Nothacker; A Bourson; A Ardati; R A Henningsen; J R Bunzow; D K Grandy; H Langen; F J Monsma; O Civelli
Journal:  Science       Date:  1995-11-03       Impact factor: 47.728

  8 in total
  23 in total

1.  [Nphe(1)]-Nociceptin (1-13)-NH(2), a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats.

Authors:  J P Redrobe; G Calo; R Guerrini; D Regoli; R Quirion
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 2.  Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists.

Authors:  W Schröder; D G Lambert; M C Ko; T Koch
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

3.  Activation of brain NOP receptors attenuates acute and protracted alcohol withdrawal symptoms in the rat.

Authors:  Daina Economidou; Andrea Cippitelli; Serena Stopponi; Simone Braconi; Stefano Clementi; Massimo Ubaldi; Rèmi Martin-Fardon; Friedbert Weiss; Maurizio Massi; Roberto Ciccocioppo
Journal:  Alcohol Clin Exp Res       Date:  2011-01-11       Impact factor: 3.455

4.  Orphanin FQ/nociceptin blocks cocaine-induced behavioral sensitization in rats.

Authors:  Kabirullah Lutfy; Imran Khaliq; F Ivy Carroll; Nigel T Maidment
Journal:  Psychopharmacology (Berl)       Date:  2002-08-30       Impact factor: 4.530

Review 5.  Pharmacology of nociceptin and its receptor: a novel therapeutic target.

Authors:  G Calo'; R Guerrini; A Rizzi; S Salvadori; D Regoli
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

6.  Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin.

Authors:  S Sbrenna; M Marti; M Morari; G Calo'; R Guerrini; L Beani; C Bianchi
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 7.  Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies.

Authors:  Christin Schifani; Sina Hafizi; Tania Da Silva; Jeremy Joseph Watts; M Saad Khan; Romina Mizrahi
Journal:  Int Rev Psychiatry       Date:  2017-12-08

8.  Nociceptin Receptors Upregulated in Cocaine Use Disorder: A Positron Emission Tomography Imaging Study Using [11C]NOP-1A.

Authors:  Rajesh Narendran; Savannah Tollefson; Michael L Himes; Jennifer Paris; Brian Lopresti; Roberto Ciccocioppo; N Scott Mason
Journal:  Am J Psychiatry       Date:  2019-05-06       Impact factor: 18.112

9.  Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin-releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis.

Authors:  Donata Rodi; Silvia Zucchini; Michele Simonato; Carlo Cifani; Maurizio Massi; Carlo Polidori
Journal:  Psychopharmacology (Berl)       Date:  2007-11-07       Impact factor: 4.530

10.  Kainic acid down-regulates NOP receptor density and gene expression in human neuroblastoma SH-SY5Y cells.

Authors:  Rosalia Cannarsa; Daniela Landuzzi; Chiara Cavina; Sanzio Candeletti; Patrizia Romualdi
Journal:  J Mol Neurosci       Date:  2008-02-20       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.